{
    "organizations": [],
    "uuid": "47bef4789af1d8f7e74739e1ca51334c0909f532",
    "author": "",
    "url": "https://www.reuters.com/article/brief-ab-science-fy-operating-loss-down/brief-ab-science-fy-operating-loss-down-at-28-4-million-euros-idUSL8N1S76MQ",
    "ord_in_thread": 0,
    "title": "BRIEF-AB Science FY Operating Loss Down At 28.4 Million Euros",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 30, 2018 / 5:00 PM / Updated 7 minutes ago BRIEF-AB Science FY Operating Loss Down At 28.4 Million Euros Reuters Staff\nApril 30 (Reuters) - AB SCIENCE SA:\n* FY NET LOSS EUR 27.1 MILLION VERSUS LOSS OF EUR 27.7 MILLION YEAR AGO\n* AB SCIENCE REPORTS TODAY ITS ANNUAL FINANCIALS AS OF 31 DECEMBER 2017 AND PROVIDES AN UPDATE ON ITS ACTIVITIES\n* FY NET REVENUES EUR 1.7 MILLION VERSUS EUR 1.5 MILLION YEAR AGO\n* FY OPERATING LOSS EUR 28.4 MILLION VERSUS LOSS OF EUR 30.2 MILLION YEAR AGO\n* INTENDS TO LAUNCH BY END 2018 A PHASE 1/2 REFRACTORY ACUTE MYELOID LEUKEMIA STUDY WITH NEW MOLECULE\n* INTENDS TO LAUNCH A CONFIRMATORY PHASE 3 STUDY IN INDOLENT SYSTEMIC MASTOCYTOSIS\n* SUBJECT TO AVAILABILITY OF FINANCIAL RESOURCES, AIMS TO START IN 2018 PRECLINICAL STUDIES OF NEW MOLECULES Source text for Eikon: Further company coverage: (Gdynia Newsroom)",
    "published": "2018-04-30T19:59:00.000+03:00",
    "crawled": "2018-04-30T20:10:36.023+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "pm",
        "updated",
        "minute",
        "ago",
        "science",
        "fy",
        "operating",
        "loss",
        "million",
        "euro",
        "reuters",
        "staff",
        "april",
        "reuters",
        "ab",
        "science",
        "sa",
        "fy",
        "net",
        "loss",
        "eur",
        "million",
        "versus",
        "loss",
        "eur",
        "million",
        "year",
        "ago",
        "ab",
        "science",
        "report",
        "today",
        "annual",
        "financials",
        "december",
        "provides",
        "update",
        "activity",
        "fy",
        "net",
        "revenue",
        "eur",
        "million",
        "versus",
        "eur",
        "million",
        "year",
        "ago",
        "fy",
        "operating",
        "loss",
        "eur",
        "million",
        "versus",
        "loss",
        "eur",
        "million",
        "year",
        "ago",
        "intends",
        "launch",
        "end",
        "phase",
        "refractory",
        "acute",
        "myeloid",
        "leukemia",
        "study",
        "new",
        "molecule",
        "intends",
        "launch",
        "confirmatory",
        "phase",
        "study",
        "indolent",
        "systemic",
        "mastocytosis",
        "subject",
        "availability",
        "financial",
        "resource",
        "aim",
        "start",
        "preclinical",
        "study",
        "new",
        "molecule",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}